Intellia TherapeuticsvsThermo Fisher Scientific

NTLA and TMO stock compared: price, dividend, valuation and results, from SEC filings.

NTLA

Intellia Therapeutics, Inc.

$10.10

Value $1.4B

+4.12%
NTLA's page

TMO

Thermo Fisher Scientific Inc

$696.60

Value $259B

-0.52%
TMO's page

Intellia Therapeutics (NTLA) has a market value of $1.4B and Thermo Fisher Scientific (TMO) $259B. Over the last year, with dividends, NTLA moved +16.1% and TMO +20.8%. Dividend yield: NTLA none, TMO 0.26%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    NTLA$1.4B

    TMO$259B

    TMO is 183 times NTLA

  • Revenue, 12 months

    NTLA$53M

    TMO$47.4B

    TMO is 895 times NTLA

  • Net income, 12 months

    NTLA-$426M

    TMO$7.1B

  • Operating margin

    NTLA-821.2%

    TMO17.9%

    839.1 points apart

  • ROIC

    NTLA-50.7%

    TMO8.2%

    58.9 points apart

  • P/E

    NTLA–

    TMO36.6

  • Dividend yield

    NTLA0.0%

    TMO0.3%

    0.3 points apart

  • 5-year return

    NTLA-92.4%

    TMO+11.7%

    104.1 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

NTLA-92.4%

TMO+11.7%

05010020222023202420252026
Returns by period
PeriodNTLAWith dividendsTMOWith dividends
1 year since November 14, 2025+16.1%Price +16.1%+20.8%Price +20.4%
3 years since November 16, 2023-61.2%-27.1% a yearPrice -61.2%+48.9%+14.2% a yearPrice +47.4%
5 years since November 15, 2021-92.4%-40.3% a yearPrice -92.4%+11.7%+2.2% a yearPrice +10.2%
10 years since November 16, 2016-42.4%-5.4% a yearPrice -42.4%+379.3%+17.0% a yearPrice +366.0%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

NTLAIntellia TherapeuticsTMOThermo Fisher Scientific

Valuation

NTLATMO
Valuation
Price$10.10$696.60
Market value$1.4B$259B
Enterprise value (EV)$1.0B$294B
P/E–36.6
P/E, 5-year median–32.7
P/B2.34.7
EV/EBIT–34.7
Free cash flow yield–2.9%

Results and growth

NTLATMO
Results and growth
Revenue, 12 months$53M$47.4B
Net income, 12 months-$426M$7.1B
Free cash flow, 12 months-$358M$7.6B
Earnings per share, 12 months-$3.34$18.96
Revenue growth, year on year16.9%3.9%
Revenue growth a year, past+3.1%over 5 years+6.7%over 5 years
EPS growth a year, past–+2.1%over 5 years

Margins and returns on capital

NTLATMO
Margins and returns on capital
Gross margin––
Operating margin-821.2%17.9%
Net margin-805.7%14.9%
ROIC-50.7%8.2%
ROE-63.0%13.4%

Balance sheet

NTLATMO
Balance sheet
Cash$474M$6.1B
Total debt$230M$41.4B
Net debt / EBITDA–3.7
Interest cover–5.5×

Dividends and buybacks

NTLATMO
Dividends and buybacks
Dividend yield–0.3%
Dividend per share, 12 months–$1.84
Dividend growth a year, past–+14.3%over 5 years
Buyback yield–1.2%
Shareholder yield–1.4%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: NTLA or TMO

Didn't find what you were looking for?

Ask us
Which is bigger, Intellia Therapeutics or Thermo Fisher Scientific?

By market value, Thermo Fisher Scientific ($259B) is about 182.5 times Intellia Therapeutics ($1.4B), at today's prices.

How did NTLA and TMO stock do over the last 10 years?

Since November 16, 2016, NTLA's price moved -42.4% and TMO's +366.0%. With dividends: NTLA -42.4% (-5.4% a year), TMO +379.3% (+17.0% a year). Past returns do not predict future ones.

Which pays the higher dividend, NTLA or TMO?

The dividend yield at today's price is none for Intellia Therapeutics and 0.26% for Thermo Fisher Scientific. Over the last twelve months they paid – and $1.84 per share.

Which has the higher profit margins, Intellia Therapeutics or Thermo Fisher Scientific?

Over the last twelve months, the net margin was -805.7% for Intellia Therapeutics and 14.9% for Thermo Fisher Scientific, and the operating margin -821.2% and 17.9%. Revenue was $53M and $47.4B.

Which is the better investment, Intellia Therapeutics or Thermo Fisher Scientific?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.